Pending Application of Camden, et al., U.S. patent application Ser. No. 09/676,034, filed Sep. 29, 2000. (6643R2). |
Pending Application of Camden, et al., U.S. patent application Ser. No. 09/676,032, filed Sep. 29, 2000. (6643R5). |
Pending Application of Camden, et al., U.S. patent application Ser. No. 09/676,031, filed Sep. 29, 2000. (6643R6). |
Pending Application of Camden, et al., U.S. patent application Ser. No. 09/670,166, filed Sep. 26, 2000. (8253). |
Pending Application of Camden, U.S. patent application Ser. No. 09/703,955, filed Nov. 1, 2000. (8315). |
Pending Application of Quada, Jr., et al., U.S. patent application Ser. No. 10/132,545, filed Apr. 25, 2002 (8252D). |
Pending Application of Camden, U.S. patent application Ser. No. 10/106,429, filed Jul. 18, 2002 (7719C). |
Pending Application of Camden, et al., U.S. patent application Ser. No. 10/267,051, filed Oct. 8, 2002 (8251D). |
Pending Application of Camden, U.S. patent application Ser. No. 10/280,100, filed Oct. 24, 2002 (8315C). |
Pending Application of Camden, filed Jan. 13, 2002 (6643C). |
Chemical Abstract, “1H-Benzimidazole-1-carboxamide, 2-amino-N-(1,1-dimethyl”, Registry No. 70665-72-4, (1979), American Chemical Society. |
Chemical Abstract, “Carbamic Acid”, Registry No. 83601-82-5, (1982), American Chemical Society. |
Agarwal, et al., “Antiparasitic agents. Part XVI. Synthesis of 5(6)-substituted benzimidazole-2-carbamates as anthelmintic agents”, Indian J. Chem., Sect. B, 32B(4), pp. 453-456, (1993), American Chemical Society, (abstract only). |
Agarwal, et al., “Segregation of activity profile in benzimidazoles: Effect of spacers at 5(6)-position of methyl benzimidazole-2-carbamates”, Z. Naturforsch., C: Biosci., 48(11-12), pp. 829-838, (1993), American Chemical Society, (abstract only). |
Agrawal, et al., “Synthesis of 2-substituted 5(6)-aroylaminobenzimidazoles as potential anthelmintics”, Indian J. Chem., Sec. B, 22B(2), pp. 146-149, (1983), American Chemical Society (abstract only). |
Atassi, et al., “R17934-NSC 238159: A New Antitumor Drug”, pp. 599-607, (1975), Europ. J. Cancer, vol. 11, Pergamon Press. |
Aur, “Treatment of Parasitic Infestation in Children with Malignant Neoplams” pp. 129-131, (1971), The Journal of Pediatrics, vol. 78, No. 1, Mosby, Inc. |
Beard, “5 (6)-Benzeme ring-substituted benzimidazole-2-carbamate derivative having anthelmintic activity”, U.S. patent 4,086,235 A, (1978), American Chemical Society (abstract only). |
Bekish, et al., “Search for active drugs from a group of benzimidazolecarbamates for the treatment of trichinosis”, Vitebsk. Med. Inst., Vitebsk, USSR, Med. Parazitol. Parazit. Bolezni, pp. 32-35, (1979), American Chemical Society (abstract only). |
Berg et al., “Synergistic effects of photoactivated tetra(4-sulfonatophenyl) porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival.”, Journal of Photochemistry and Photobiology B: Biology, vol. 13, pp. 59-70, (1992) Elsevier Sequoia. |
Berg et al., “Synergistic effects of photoactivated tetra(4-sulfonatophenyl) porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival.”, Journal of Photochemistry and Photobiology B: Biology, vol. 13, pp. 59-70, (1992), American Chemical Society, (abstract only). |
Bissery, et al., “Docetaxel in Vivo Combination Chemotherapy”, pp. 3-16, (1995), Seminars in Oncology, vol. 22, No. 6-S13, W.B. Saunders Company. |
Brabender, et al., “The Effects of Methyl[5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate, (R 17934; NSC 238159), a New Antitumoral Drug Interfering with Microtubules”, pp. 905-916, (1976), Cancer Research, vol. 36, American Association of Cancer Research. |
Brown, et al., “Antiparasitic Drugs. IV. 2-(4′-Thiazolyl)-Benzimidazole, A New Anthelmintic”, pp. 1764-1765, (1961), Journal of American Chemical Society, American Chemical Society. |
Carter et al., “Drug-Tumor Interactions”, pp. 362-365, (1981), Chemotherapy of Cancer, 2nd Ed., John Wiley & Sons. |
Carter, “2-(α-Hydroxybenzyl)-Benzimidazole”, pp. 277-346, (1975), Selective Inhibitors of Viral Functions, CRC Press, Inc. |
Chimeno, Process for the preparation of alkyl N′-alkylcarbamoyl-N-(2-benzimidazolyl) carbamates, (1987), Chemical Abstracts 107:39817, American Chemical Society. |
Daum et al., “2,4-Dioxo-1, 2, 3, 4-tetrahydro-s-triazino [1,2-a] benzimidazoles”, Chemical Abstract 86:155704, (1977), American Chemical Society, (abstract only). |
Delatour, et al., “Embryonic and Antimitotic Properties in the Benzimidazole Series”, pp. 505-515, (1976), Therapie, vol. 31, No. 4, John Libbey & Co., Ltd., (English translation thereof). |
Divakar, et al., “Synthesis and antifilarial activity of benzimidazole-2-carbamates carrying an amino acid side chain at the 5(6)-position”, Indian J. Chem., Sect. (B), 28B(3), pp. 252-260, (1989), American Chemical Society (abstract only). |
Dubey, et al., “Synthesis and anthelmintic activity of 5(6)-[benzimidazole-2-yl) carboxamido]- and 4-substituted piperazin-l-y) benzimidazoles”, J. Med. Chem., 28(11), pp. 1748-17-50, (1985), American Chemical Society (abstract only). |
Dubey, et al., “Synthesis of 4-(aryl/arylcarbonyl)amino- and 4-arylthio/arylsulfonyl-7-chloroquinolines as potential antiparasitic agents”, Indian J. Chem., Sect. B, 24B(4), pp. 408-413 (1985), American Chemical Society (abstract only). |
Dupont, “‘Benlate’ Fungicide”, pp. 1-9, (1994), Materials Safety Data Sheet, DuPont. |
Elgebaly, et al., “Reversal of gamma-Radiation-Induced Leukemogenesis in Mice by Immunomodulation with Thiabendazole and Dinitrofluorobenzene”, pp. 811-815 (1985), Chemical Abstracts 102:217569, American Chemical Society. |
Elgebaly, et al., “Reversal of gamma-Radiation-Induced Leukemogenesis in Mice by Immunomodulation with Thiabendazole and Dinitrofluorobenzene”, pp. 811-815 (1985), J. Natl. Cancer Inst., Oxford University Press. |
Friedman, et al., “Interaction of Anthelmintic and Benzimidazole Dervaives with Bovine Brain Tubulin”, pp. 605-614, (1978), Biochimica et Biophysica Acta, Elsevier/North-Holland Biomedical Press. |
Gao, et al., “Antihydatidosis drugs: synthesis of benzimidazoles”, Zhongguo Yiyao Gongye Zazhi, 20(3), pp. 110-115, (1989), American Chemical Society (abstract only). |
Georgopapadakou, et al., “Human Mycoses: Drugs and Targets for Emerging Pathogens”, pp. 371-373, (1994), Science, vol. 264, American Association for the Advancement of Science. |
Ghannoum, et al., “Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth”, pp. 308-320, (1990), Chemical Abstracts 113:112365, American Chemical Society. |
Graubaum, et al., “Acylation of Heterocytes with Carbonic Acid Derivatives”, pp. 809-815, (1982), Chemical Abstract 98:52877, American Chemical Society. |
Grenda, et al., “Novel Preparation of Benzimidazles from N-Arylamidines. New Synthesis of Thiabendazole”, pp. 259-261, (1965), Journal of Organic Chemistry, vol. 30, Academic Press. |
Gruendemann, et al. “NMR Investigations of benzheterozoles. 2. NMR Investigations of N-acylated 2-aminobenzimidazoles”, pp. 21-30, (1986), Chemical Abstract 105:133247, American Chemical Society. |
Hoover et al., “Benzimidazolyl Ureas, Chemical Abstract 70:11697, (1969), American Chemical Society, (abstract only). |
Katiyar, et al., “Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence”, pp. 2086-2090, (1994), Chemical Abstracts 121:175012z, American Chemical Society. |
Katiyar, et al., “In Vitro Susceptibilities of the AIDS-Associated Microsporidian Encephalitozoon intestinalis to Albendazole, Its Sulfoxide Metabolite, and 12 Additional Benzimidazole Derivatives”, Antimicrobial Agents and Chemotherapy, (1997), pp. 2729-2732, vol. 41, No. 1, American Chemical Society. |
Khasanov, et al., “Synthesis of alkyl esters of benzimidazolyl-2-carbamic acid”, Inst. Khim. Rastit. Veschestv, Tashkent, USSR, Khim. Prir. Soedin., pp. 704-706, (1979), American Chemical Society (abstract only). |
Kumar et al., “Antiparasitic agents. Part XI. Synthesis and anthelmintic activity of 1-substituted 6-/8-[2-carbomethoxyamino)benzimidazole]-5-carbonlyamino-9H-pyrido [3,4-b] indoles”, Indian J. Chem., Sect B, 29B(11), pp. 1077-1080, (1990), American Chemical Society, (abstract only). |
Kumar, et al., “Synthesis and anthelmintic activity of alkyl 5(6)-(substituted carbamoyl)- and 5(6)-(disubstituted carbamoyl)benzimidazole-2-carbamates and related compounds”, J. Med. Chem., 27(8), pp. 1083-1089, (1984), American Chemical Society (abstract only). |
Lacey, et al., “Activity of Benzimidazole Carbamates against L1210 Mouse Leukemia Cells Correlation with in vitro Tubulin Polymerization Assay”, pp. 3603-3605 (1985), Biochemical Pharmacology, vol. 34, No. 19, Pergamon Press Ltd. |
Lacey, et al., “Structure-Activity Relationships of Benzimidazole Carbamates as Inhibitors of Mammalian Tubulin, in vitro”, pp. 1073-1077 (1985), Biochemical Pharmacology, vol. 34, No. 7, Pergamon Press Ltd. |
Lacey, et al., “The Role of the Cytoskeletal Protein, Tubulin, in the Mode of Action and Mechanism or Drug Resisteance to Benzimidazoles”, pp. 885-936, (1988), International Journal of Parasitology, vol. 18, No. 7, Pergamon Press Ltd. |
Lapras, et al. “Experimental Study of the Potential Anticancerous Properties of Parbendazole (SKF 29044)”, pp. 379-397, (1975), Bull. Soc. Sci. Vet. et Med. comparee, Lyon, vol. 77, No. 6, Societe des Sciences veterinaries et de Medecine comparee de Lyon, (in French and English translation thereof.). |
Latif et al., “Relationship between the anthelmintic activity of eight derivatives of benzimidazole carbamates against Trichinella spiralis and their chemical structures,” Jpn. J. Med. Sci. Biol., 46(5-6), pp. 203-214, (1993), American Chemical Society, (Abstract Only). |
Lessnau, et al., “Disseminated Strongyloides stercoralis in Human Immunodeficiency Virus-infected Patients”, pp. 119-122, (1993), Chest, vol. 104, American College of Chest Physicians. |
Lovett, “Immunomodulating Effects of Thiabendazole: Immunotherapeutic Efficacy in the Treatment of Murine Fibrosarcoma”, pp. 5315-5316, (1979), Dissertation Abstract International, Health Science, Immunology, vol. 39, No. 11, U M I. |
Lundy, et al., “Chemoimmunotherapy of a murine fibrosarcoma: critical factors for success of combined modality therapy”, pp. 339-345, (1977), Chemical Abstracts 87: 161659, American Chemical Society. |
Lundy, et al., “Immunomodulation with Thiabendazole: A Review of Immunologic Properties and Efficacy in Combined Modality Cancer Therapy”, pp. 1955-1962, (1978) Cancer Treatments Reports, vol. 62, No. 11, U.S. Department of Health, Education and Welfare. |
Lundy, et al., “Thiabendazole: A New Immunopotentiator Effective in Therapy of Murine Fibrosarcoma”, pp. 132-134, (1976), Surgical Forum, vol. 27, No. 62, American College of Surgeons. |
Marinovich, et al., “Mixtures of Benomyl, Primiphos-Methyl, Dimethoate, Diazinon and Azinphos-Methyl Affect Protein Synthesis in HL-60 Cells Differently”, pp 173-85, (1994), Toxicol., vol. 94, Elsevier Science Ireland Ltd. |
Menzel, et al., “Effects of some systemic fungicides on viral multiplication”, pp. 353-362, (1979), Chemical Abstracts 92:123231, American Chemical Society. |
The Merck Index, Twelfth Edition, “7943: Procodazole”, p. 1333, and “9877: Tripolidine”, pp. 1660-1661, (1996), Merck Research Laboratories. |
The Merck Index, Eighth Edition, “Thiabendazole”, p. 1035, (1968), Merck & Co., Inc. |
Naim, et al. “Studies in antiparasitic agents. Part II. Synthesis of 5-substituted 2-alkyl(aryl)carbonylaminobenzimidazoles as orally effective anthelmintics”, Indian J. Chem., Sect. B, 29B(5), pp. 464-470, (1990), American Chemical Society, (abstracts only). |
NASR et al., “Computer Assisted Structure-Anticancer Activity Correlations of Carbamates and Thiocarbamates”, Journal of Pharmaceutical Sciences, pp. 831-836, (1985), American Pharmaceutical Association. |
Nene, et al., “Systemic Fungicides”, pp. 208-386, (1993), Fungicides in Plant Disease Control, Third Edition, Ch. 9, International Science Publisher. |
Niwas et al. “Possible anthelmintic agents. Synthesis of 4-aryl-2, 5-dimethyl-3-(N,N-disubstituted carbamoyl)furans, substituted isoquinolino [1,2-b]-quinazolines and methyl 5(6)-substituted benzimidazole-2-carbamates”, Indian J. Chem., Sect. B, 24B(7), pp. 754-760, (1985), American Chemical Society (abstract only). |
Paget et al., “Heterocyclic Substituted Ureas. I. Immunosuppression and Virus Inhibition by Benzimidazoleureas”, Journal of Medicinal Chemistry, vol. 12, pp. 1010-1915, (1969), American Chemical Society. |
Paget et al., “Heterocyclic Substituted Ureas. I. Immunosuppression and Virus Inhibition by Benzimidazoleureas”, Chemical Abstract 72: 12644, (1970), American Chemical Society, (Abstract only). |
Paget et al., “Antiviral and immunization reaction-suppressing compounds containing an N-heterocyclics ureas compound”, Chemical Abstract 73:87920, (1970), American Chemical Society, (Abstract only). |
Park, “An Inquiry into the Etiology of Cancer”, The American Journal of the Medical Sciences, vol. 115, No. 5., pp. 504-520, (1898), Lippincott Williams & Wilkins. |
Private Communication to Dr. Von Hoff from National Institute of Health, National Cancer Society (Sep. 18, 1995). |
Rajappa, et al., “A novel synthesis of 5-acylaminobenzimidazole-2-carbamates: Intramolecular regioselective addition to quinone-imides”, Tetrahedron Lett., 24(30), pp. 3155-3158, (1983), American Chemical Society (Abstract only). |
Rajappa, et al., “Quinone imine route to benzimidazol-2-ylcarbamates. Part 1. Synthesis of open-chain and cyclic 5-acylamino derivatives”, J. Chem. Res., Synop., (5), pp. 158-159, (1986), American Chemical Society (Abstract only). |
Rajappa, et al., “Selective functionalization in 2-nitro-p-phenylenediamine. Part I. Synthesis of derivatives of 5-aminobenzimidazole”, Indian J. Chem., Sect B., 19B(7), pp. 533-535, (1980), American Chemical Society (Abstract only). |
Ram, et al., “Synthesis and Biological Activity of Certain Alkyl 5-(Alkoxycarbonyl)-1H-Benzimidazole-2-carbmates and Realted Derivatives: A New Class of Potential Antineoplastic and Antifilarial Agents”, pp. 539-547, (1992), Journal of Medicinal Chemistry, vol. 35, No. 3, American Chemical Society. |
Sawhney, et al., “Synthesis of some benzimidazole derivatives as potential anthelmintics”, Indian J. Chem., Sect. B, 28B(7), pp. 574-578, (1989), American Chemical Society, (Abstract only). |
Setoi et al. “Preparation of benzamide derivatives having a vasopressin antagonistic activity”, Chemical Abstract 129:67773, (1998), American Chemical Society. |
Sokhanenkova, “Characteristics of the cholinesterase system of ascarids and the effect on it of benzimidazole carbamates”, Tr. Gel'mintol. Lab., Akad. Nauk SSSR, 32, pp. 154-159, (1984), American Chemical Society (Abstract only). |
Srivastava, et al., “Synthesis of 2,5-disubstituted benzimidazoles, 1,3,4-thiadiazoles and 3,5-diiodosalicylanilides as structural congeners of rafoxanide and closantel”, Pharmazie, 45(1), pp. 34-37, (1990), American Chemical Society (Abstract only). |
Stedman's Medical Dictionary, 24th Edition, “Leukemia”, pp. 777-778, (1983), Williams & Wilkins. |
Tanneberg, et al., “Substituted Benzimidazolecarbmates”, p. 7, (1985), Chemical Abstracts 102:24617, American Chemical Society. |
Teicher, et al., “Potentiation of Cytotxic Therapies by TNP-470 and Minocycline in Mice Bearing EMT-6 Mammary Carcinoma”, pp. 227-236, (1995), Breast Cancer Research and Treatment, vol. 36, Kluwer Academic Publishers. |
Thomson, “Fungicides”, pp. 154, 121, 123, (1993-1994) Revision), Agricultural Chemicals Book IV, Thomson Publications. |
Vergieva, “Carbendazim teratogenic activity of rats”, pp. 333-339, (1982), Chemical Abstracts 98:66765, American Chemical Society. |
Visen, et al., “Speed of action of methyl 5(6)-[4-(2-pyridyl)]piperazinocarbamoylbenzimidazole-3-carbamate, mebendazole and thiabendazole against experimental hookworm infections”, Indian J. Exp. Bio., 25(10), pp. 695-699, (1987), American Chemical Society (Abstract only). |